Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1109448 NASHVILLE, TN
Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,875,024
+$751,904 QoQ
Shares Held
104,400
+29.2% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 207 holders
Holding Since
Jun 2022
13 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $485,105,474 across 44 Drug Manufacturers - Specialty & Generic names. AMLX ranks #20 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 234,607 $127,117,110
2 NBIX
Neurocrine Biosciences Inc
 461,270 $77,742,445
3 RDY
Dr Reddys Laboratories Ltd
 3,730,713 $54,058,031
4 ZTS
Zoetis Inc.
 698,452 $50,190,760
5 KNSA
Kiniksa Pharmaceuticals International, plc
 556,151 $35,565,856
6 VTRS
Viatris Inc
 1,233,234 $19,583,755
7 ELAN
Elanco Animal Health Inc
 621,675 $15,299,421
8 HIMS
Hims & Hers Health, Inc.
 438,863 $15,215,380

All Filings in AMLX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,875,024 104,400
2026-03-31 $1,123,120 80,800
2025-12-31 $863,720 71,500
2025-09-30 $971,685 71,500
2025-06-30 $196,146 30,600
2024-03-31 $146,379 51,542
2023-12-31 $758,698 51,542
2023-09-30 $943,734 51,542
2023-06-30 $1,111,760 51,542
2023-03-31 $1,512,242 51,542
2022-12-31 $1,339,141 36,242
2022-09-30 $1,020,212 36,242
2022-06-30 $691,434 35,900